Efficacy of danazol treatment in infertile patients with endometriosis.
article
OA: closed
CC0
Abstract
The study was done to assess the efficacy of danazol in the treatment of infertile patients with all stages of endometriosis. The cumulative pregnancy rates in 21 patients with Stage I and II endometriosis were compared to 21 patients with Stage III and IV endometriosis. Both groups had danazol treatment for six months. All other fertility related factors were controlled for in both groups. There was a cumulative pregnancy rate of 11% (standard error 7%) at 12 months of follow-up in the group with Stage I and II disease whilst it was 26% (standard error 10%) in the group with moderate or severe disease. These results question the validity of any classification system in prognosticating for fertility in patients with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (10)
- An Expanded Classification of Endometriosis via openalex
- A proposed classification of pelvic endometriosis. via openalex
- Efficacy of danazol treatment for minimal endometriosis in infertile women. A prospective, randomized study. via openalex
- Recurrent endometriosis: Incidence, management, and prognosis via openalex
- The effectiveness of danazol on subsequent fertility in minimal endometriosis via openalex
- W2346704459 via openalex
- W2401321122 via openalex
- W2270444753 via openalex
- W2409648342 via openalex
- W2415755045 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:11:49.821429+00:00
License: CC0
· commercial use OK